1HEINRICH M,LEE T.Galanthamine from snowdrop the devel-opment of a modern drug against Alzheimer's disease from local caucasian knowledge[J].J Ethnopharmacol,2004,92(2-3):147-162.
2SONKUSARE S K,KAUL C L,RAMARAO P.Dementia of Alzh-eimer's disease and other neurodegenerative disorders--memantine,a new hope[J].Pharmacol,2005,51(1):1-17.
3STANDRIDGE J B.Pharmacotherapeutic approaches to the treatment of Alzheimer's disease[J].Clin Ther,2004,26(5):615-30.
4DAIELLO L A.Current issues in dementia pharmacotherapy[J].Am J Manag Care,2007,13 (Suppl 8):198-202.
5BIRKS J.Cholinesterase inhibitors for Alzheimer's disease[J].Cochrane Database Syst Rev,2006,25(1):53-59.
8WINBLAD B,KILANDER L,ERIKSSON S,et al.Donepezil in pa-tients with severe Alzheimer's disease:double-blind,parallel-group,placebo-controlled study[J].Lancet,2006,367(9516):1057-1065.
9KADUSZKIEWICA H,ZIMMERMANN T,BECK-BORNHOLDT H P.Cholinesterase inhibitors for patients with Alzheimer's disease:systematic review of randomised clinical trials[J].BMJ,2005,331(2):321-327.
10LANDMARK K,REIKVAM A.Cholinesterase inhibitors in the trea-tment of dementia--are they useful in clinical practice[J].Tidsskr Nor Laegeforen,2008,31(3):294-297.
